Advent Capital Management’s Pfizer PFE Stock Holding History

Advent Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$2.88M	–	196
2023 Q4	$2.88M	Buy	+100,000	New	+$3.02M	0.07%	144
2020 Q2	–	Sell	-158,100	Closed	-$4.9M	–	197
2020 Q1	$4.9M	Buy	+158,100	New	+$5.39M	0.11%	135
2019 Q3	–	Sell	-79,050	Closed	-$3.25M	–	232
2019 Q2	$3.25M	Sell	79,050 -26,350	-25%	-$1.05M	0.06%	157
2019 Q1	$4.25M	Buy	105,400 +89,590	+567%	+$3.59M	0.09%	137
2018 Q4	$655K	Buy	15,810 +15,640	+9,200%	+$649K	0.02%	165
2018 Q3	$7K	Buy	+170	New	+$6.54K	﹤0.01%	257
2018 Q2	–	Sell	-5,270	Closed	-$177K	–	314
2018 Q1	$177K	Buy	+5,270	New	+$181K	﹤0.01%	236
2017 Q4	–	Sell	-26,350	Closed	-$893K	–	303
2017 Q3	$893K	Buy	+26,350	New	+$847K	0.02%	177
2017 Q1	–	Sell	-24,242	Closed	-$764K	–	302
2016 Q4	$747K	Buy	+24,242	New	+$740K	0.01%	192
2016 Q3	–	Sell	-14,756	Closed	-$493K	–	518
2016 Q2	$493K	Buy	+14,756	New	+$471K	0.01%	353
2015 Q2	–	Sell	-68,510	Closed	-$2.23M	–	540
2015 Q1	$2.26M	Hold	68,510	–	–	0.03%	300
2014 Q4	$2.02M	Sell	68,510 -88,008	-56%	-$2.52M	0.03%	318
2014 Q3	$4.39M	Sell	156,518 -1,582	-1%	-$44.4K	0.07%	258
2014 Q2	$4.56M	Buy	+158,100	New	+$4.51M	0.07%	257

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Advent Capital Management's PFE Position: Q1 2024 in Review

Advent Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 100,000 shares — an estimated $2.88M sold.

Advent Capital Management first reported a position in PFE in Q2 2014 and held it in 14 quarters. The position peaked at $4.9M in Q1 2020. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Advent Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Advent Capital Management sold 100,000 Pfizer shares in Q1 2024, an estimated $2.88M.
Advent Capital Management first reported a position in Pfizer in Q2 2014 and held it in 14 quarters.
Advent Capital Management's Pfizer position peaked at $4.9M in Q1 2020.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Advent Capital Management's 13F filing for Q1 2024, filed 14 May 2024.